Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer. Read more about Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer. Read more about A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer.
Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas. Read more about Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas.
Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Read more about Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
Socioeconomic disparities in timeliness of care and outcomes for anal cancer patients. Read more about Socioeconomic disparities in timeliness of care and outcomes for anal cancer patients.
Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studie Read more about Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studie
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit). Read more about Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).
Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Read more about Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer.
Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases. Read more about Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.
Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma. Read more about Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.
